Qihan Biotechnology scores $67m
Qihan Biotechnology Co, a Chinese provider of genome editing technology to cell therapies and organ transplantation, has raised $67 million in financing.
Qihan Biotechnology Co, a Chinese provider of genome editing technology to cell therapies and organ transplantation, has raised $67 million in financing.
Copyright PEI Media
Not for publication, email or dissemination